Kueck et al.’s study, which evaluated the impact of RV on the viability and glucose uptake of five human ovarian cancer cell lines, revealed that treatments lasting up to eight hours could decrease cell viability, lactate production, glucose uptake, Akt, and mammalian target of rapamycin (mTOR) signaling in a manner that was dependent on time and dose [42,43]. This evidence concerns the gene MTOR and ovarian cancer.